학술논문
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
Document Type
Article
Author
Dasyam, N.; Bauer, E.; Mester, B.; Wood, C.E.; Authier-Hall, A.; Lowe, J.; Maxwell, A.; Burn, O.K.; Weinkove, R.; Gasser, O.; Hermans, I.F.; Sharples, K.J.; Huang, Y.; Hinder, V.A.; Macapagal, J.; McCusker, M.; Findlay, M.P.; Barrow, C.; Dzhelali, M.; Ostapowicz, T.; Kumar, R.; Williams, G.M.; Carley, S.E.; Brimble, M.A.; Dunbar, P.R.; Caygill, G.; Jones, J.; Chan, S.T.S.; Painter, G.F.
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, July 2023, 72(7):2267-2282)
Subject
Language
English
ISSN
14320851
03407004
03407004